deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT03539224

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

Sponsor: Instituto de Investigación Hospital Universitario La Paz

Conditions HIV-1-infection
Interventions Dolutegravir (DTG) Lamivudine (3TC)
Updated 9 times since 2018 Last updated: Jul 6, 2020 Started: Nov 2, 2017 Primary completion: May 31, 2021 Completion: Jul 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on HIV-1-infection, this trial is ongoing. The trial is conducted by Instituto de Investigación Hospital Universitario La Paz and has accumulated 9 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshotRecruiting~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshotRecruiting~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshotActive Not Recruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotActive Not Recruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Sep 2022 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  4. Jan 2021 — Sep 2022 [monthly]

    Active Not Recruiting PHASE2

  5. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

▶ Show 4 earlier versions

  1. Sep 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Sep 2018 — Sep 2019 [monthly]

    Recruiting PHASE2

  3. Jul 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  4. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto de Investigación Hospital Universitario La Paz
Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations